These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8922201)

  • 21. [Insomnia therapy and withdrawal of hypnotics].
    Garma L; Widlöcher D; Scherrer J
    Sem Hop; 1982 Nov; 58(42):2441-9. PubMed ID: 6297032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insomnia symptoms among old people in nursing homes.
    Skottheim A; Lövheim H; Isaksson U; Sandman PO; Gustafsson M
    Int Psychogeriatr; 2018 Jan; 30(1):77-85. PubMed ID: 28927479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes.
    Avidan AY; Fries BE; James ML; Szafara KL; Wright GT; Chervin RD
    J Am Geriatr Soc; 2005 Jun; 53(6):955-62. PubMed ID: 15935017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of the therapeutic management of insomnia with zolpidem.
    Lee YJ
    CNS Drugs; 2004; 18 Suppl 1():17-23; discussion 41, 43-5. PubMed ID: 15291010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypnotic drugs for 1984.
    Oswald I
    Psychopharmacology Suppl; 1984; 1():84-90. PubMed ID: 6147844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ; Goa KL
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of insomnia in hospitalized patients.
    Berlin RM
    Ann Intern Med; 1984 Mar; 100(3):398-404. PubMed ID: 6141753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors contributing to sleep disturbance and hypnotic drug use in hemodialysis patients.
    Noda A; Nakai S; Soga T; Sugiura T; Iwayama N; Maeda K; Atarashi M; Yasuma F; Ozaki N; Yokota M; Koike Y
    Intern Med; 2006; 45(22):1273-8. PubMed ID: 17170500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utilization of hypnotics in chronic schizophrenics: some critical remarks.
    Jus K; Jus A; Villeneuve A; Pires P; Fontaine P
    Biol Psychiatry; 1979 Dec; 14(6):955-60. PubMed ID: 41605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of insomnia.
    Byerley B; Gillin JC
    Psychiatr Clin North Am; 1984 Dec; 7(4):773-89. PubMed ID: 6542995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypnotics: rebound insomnia and residual sequelae.
    Nicholson AN
    Br J Clin Pharmacol; 1980 Mar; 9(3):223-5. PubMed ID: 7362730
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of zaleplon in the treatment of insomnia.
    Israel AG; Kramer JA
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An assessment of short-acting hypnotics.
    Mendelson WB; Jain B
    Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness of nine hypnotic drugs: sleep laboratory studies.
    Kales A; Bixler EO; Kales JD; Scharf MB
    J Clin Pharmacol; 1977 Apr; 17(4):207-13. PubMed ID: 321488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
    Lähteenmäki R; Neuvonen PJ; Puustinen J; Vahlberg T; Partinen M; Räihä I; Kivelä SL
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):330-340. PubMed ID: 30295409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Treatment of Insomnia Symptoms in Individuals with Substance Use Disorders in Spain: A Quasi-Experimental Study.
    Grau-López L; Grau-López L; Daigre C; Palma-Álvarez RF; Rodriguez-Cintas L; Ros-Cucurull E; Roncero C
    Subst Use Misuse; 2018 Jul; 53(8):1267-1274. PubMed ID: 29185897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
    Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
    Health Technol Assess; 2004 Feb; 8(8):iii-iv, 1-68. PubMed ID: 14960254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.